Jacobs Capital Group, LLC Launches New $125 Million Fund
Jacobs Capital Group to invest in emerging managers with various industry specialties and geographic focuses, promoting synergies among the various portfolio funds.
Pasadena, CA (PRWEB) August 10, 2006
Jacobs Capital Group, LLC (JCG) announced today it has launched a private equity fund to invest in alternative investments such as venture capital funds. The fund-of-funds will primarily invest in emerging managers with various industry specialties and geographic focuses, promoting synergies among the various portfolio funds.
“We hope to increase the success of our portfolio funds by encouraging the managers to share best practices, deal flow, industry and technical expertise, contacts, and other resources,” said Alex Suh, Managing Director of JCG. “We can’t all be experts in everything, so having access to managers in different industries and global and national regions can be extremely valuable.”
JCG has recently made initial investments in California Technology Ventures II, LLC, Aphelion Medical Fund, Innovations Kapital IV, and Psilos Ventures III. California Technology Ventures (http://www. CTVentures. com (http://www. CTVentures. com)) is a Pasadena-based fund investing in technology and life science companies with a hands-on, entrepreneurial approach. Aphelion Medical Fund is a San Francisco-based fund investing in leading medical devices companies, public and private. Innovations Kapital (http://www. innkap. se (http://www. innkap. se)) is a Swedish-based venture fund investing in early stage ICT and Healthcare & Life Sciences companies primarily in the Nordic region. Psilos Ventures (http://www. psilos. com (http://www. psilos. com)), headquartered in New York, specializes in mid - to later-stage healthcare services, healthcare IT, and medical devices investments.
For more information, please visit JCG’s website at http://www. JacobsCapitalGroup. com (http://www. JacobsCapitalGroup. com)
# # #
